# NetEase, Inc.: Form 20-F for the period ended Dec 31, 2023

- Company: [NetEase, Inc.](/companies/ntes.md) (CIK 1110646)
- Form: 20-F
- Filed: 2024-04-25
- Accepted by EDGAR: Apr 25, 2024, 06:03 ET
- Period: 2023-12-31
- Accession: 0001104659-24-051449
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1110646/000110465924051449/ntes-20231231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1110646/000110465924051449/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | $14.57bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2023-01-01 to 2023-12-31 | $5.69bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2023-01-01 to 2023-12-31 | $8.88bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2023-01-01 to 2023-12-31 | $2.32bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | $3.90bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | $661.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | $4.13bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | $1.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | $1.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-01-01 to 2023-12-31 | 3,252,029,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | $4.98bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | $324.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2023-01-01 to 2023-12-31 | $1.13bn | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2023-12-31 | $3.02bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-12-31 | $20.10bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | $26.19bn | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | $7.58bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-12-31 | $8.15bn | us-gaap:Liabilities |
| Long-term debt | at 2023-12-31 | $60.3m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2023-12-31 | $17.51bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2023-12-31 | 3,210,783,141 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1110646/000110465924051449/ntes-20231231x20f.htm

Filed Apr 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-051449. Last ingested by Listed: Nov 12, 2026, 17:12 ET. No prices; not investment advice.
